Article

Daily Medication Pearl: Voriconazole (Vfend)

Voriconazole (Vfend) is an azole antifungal indicated for the treatment of invasive aspergillosis and Candidemia in non-neutropenics and other deep tissue Candida infections.

Medication Pearl of the Day: Voriconazole (Vfend)

Indication: Voriconazole (Vfend) is an azole antifungal indicated for the treatment of adults and pediatric patients 2 years of age and older with invasive aspergillosis and Candidemia in non-neutropenics and other deep tissue Candida infections.

Insight:

  • Dosing: May start from 4 mg/kg/day and extend to 9 mg/kg/day based on the patient.
  • Dosage forms: Tablets 50 mg, 200 mg.
  • Adverse events: The most common adverse reactions (incidence ≥2%) were visual disturbances, fever, nausea, rash, vomiting, chills, headache, liver function test abnormal, tachycardia, and hallucinations.
  • Mechanism of action: Voriconazole is an antifungal drug.

Source:

https://labeling.pfizer.com/showlabeling.aspx?id=618

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Image credit: Dr_Microbe | stock.adobe.com